ExploreWatchlistsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Diluted EPS

ABBOTT LABORATORIES (ABT)

Market cap
$154.9B
P/E ratio
24x
SummaryFinancials
Period EndDiluted EPS (USD)YoY (%)
Dec 31, 20253.7-51.31%
Dec 31, 20247.6+134.36%
Dec 31, 20233.3-16.62%
Dec 31, 20223.9-0.76%
Dec 31, 20213.9+57.60%
Dec 31, 20202.5+21.36%
Dec 31, 20192.1+54.89%
Dec 31, 20181.3+392.59%
Dec 31, 20170.3-71.28%
Dec 31, 20160.9-67.81%
Dec 31, 20152.9+80.25%
Dec 31, 20131.6-46.18%
Dec 31, 20113+1.69%
Dec 31, 20103

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat